Vutiglabridin
Modify Date: 2024-01-11 10:28:38
Vutiglabridin structure
|
Common Name | Vutiglabridin | ||
|---|---|---|---|---|
| CAS Number | 1800188-47-9 | Molecular Weight | 354.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H26O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of VutiglabridinVutiglabridin (HSG4112), a racemic compound, is a potent anti-obesity agent[1]. Vutiglabridin, an optimized structural analog of Glabridin, markedly supersedes Glabridin in weight reduction efficacy and chemical stability[1]. |
| Name | Vutiglabridin |
|---|
| Description | Vutiglabridin (HSG4112), a racemic compound, is a potent anti-obesity agent[1]. Vutiglabridin, an optimized structural analog of Glabridin, markedly supersedes Glabridin in weight reduction efficacy and chemical stability[1]. |
|---|---|
| Related Catalog | |
| In Vivo | Vutiglabridin (HSG4112) fully reverses adiposity in HFD-induced obese mice in a dose-dependent manner. Vutiglabridin (orally administered with 10, 30, or 100 mg/kg dose for 6 weeks) dose-dependently reduces body weight and normalizes obesity-related parameters in high-fat diet (HFD)-induced obese mice[2]. Animal Model: HFD-induced obese male C57BL/6J mice[2] Dosage: 10, 30, and 100 mg/kg Administration: Orally administered for 6 weeks Result: Led to significant dose-dependent body weight reduction by 4.0 g (8.3%), 10 g (21%), and 19 g (40%), respectively, compared to the 48.1 g body weight of HFD-induced obese mice administered with only the vehicle at 10, 30, and 100 mg/kg. |
| References |
| Molecular Formula | C22H26O4 |
|---|---|
| Molecular Weight | 354.44 |